drugset / Trial / NCT00380003

Efficacy Study of EVT 201 to Treat Insomnia

NCT00380003 ↗

Phase 2 Completed 66 enrolled Evotec Neurosciences GmbH
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to determine whether a compound known as EVT 201 is effective in treating people diagnosed with primary insomnia ( difficulty sleeping with no other significant contributing factor, such as depression).

Timeline

Start
2006-09
Primary completion
—
Completion
2007-04

Drugs

EvaluationDrugModalityDoseRoute
Subject DIMDAZENIL Small molecule — —